July 13, 2026 Omnicell Inc. Set to Announce Second Quarter 2026 Financial Results Omnicell, Inc. is set to announce its Q2 2026 financial results on July 30, 2026, followed by a conference call at 8:30 a.m. ET. Investors are eager to learn about the company's innovative medication management solutions and future strategies.
July 01, 2026 Omnicell Inc. Announces Leadership Change: Nnamdi Njoku Appointed President Omnicell Inc. has appointed Nnamdi Njoku as President, effective July 1, 2026, while he continues as COO. His leadership aims to enhance operational excellence and innovation in healthcare technology, particularly through the launch of new solutions like the Titan XT automated dispensing system.
June 08, 2026 Omnicell Inc. Appoints Dan Mandoli as Senior Vice President to Spearhead Specialty Pharmacy Services Omnicell, Inc. has appointed Dan Mandoli as Senior Vice President of Specialty Pharmacy Services, leveraging his 30 years of expertise to drive growth. Mandoli's proven track record in specialty pharmacy operations is expected to enhance Omnicell's offerings and improve patient outcomes.
June 02, 2026 Omnicell Inc. Set to Showcase Innovations at Goldman Sachs Healthcare Conference Omnicell, Inc. will showcase its innovative medication management solutions at the Goldman Sachs Healthcare Conference on June 9, 2026. The company aims to highlight its commitment to improving patient care through technology and expert services, with webcasts available for wider audience access.
May 06, 2026 Omnicell Inc.'s Q1 2026 Financial Report: A Step Toward Autonomous Pharmacy Omnicell Inc.'s Q1 2026 financial results reveal a 14.9% revenue growth, reaching $309.8 million. The company emphasizes automation in pharmacy care as it navigates challenges in the healthcare landscape.
May 04, 2026 Omnicell Inc. Set to Showcase Innovations at BofA Securities 2026 Healthcare Conference Omnicell, Inc. will present its latest innovations at the BofA Securities 2026 Healthcare Conference on May 12, 2026. The focus will be on enhancing medication management through automation and AI, with webcasts available for wider access.
April 29, 2026 Omnicell Inc. Strengthens Leadership Team with Appointment of Rick Couldry Omnicell, Inc. has appointed Rick Couldry as Senior Vice President and Chief Pharmacy and Clinical Officer, emphasizing its commitment to pharmacy innovation. With over 30 years of experience in hospital pharmacy leadership, Couldry aims to improve patient outcomes and align solutions with healthcare providers' needs.
April 28, 2026 Omnicell Reports Strong Q1 2026 Financial Results Omnicell, Inc. reported a strong Q1 2026 with revenues of $310 million, a 15% increase year-over-year. The company showcased its innovative solutions and revised its full-year guidance upwards, reflecting a solid financial position and strategic developments.
April 13, 2026 Omnicell Inc. Set to Release First Quarter 2026 Financial Results Omnicell, Inc. is set to announce its Q1 2026 financial results on April 28, followed by a conference call for in-depth analysis. The company continues to innovate in healthcare technology, focusing on autonomous medication management to improve patient care and operational efficiency.
February 26, 2026 Omnicell Inc. Reports 2025 Annual Results: A Year of Transformation and Challenges Omnicell, Inc. reported a revenue increase to $1.18 billion in 2025, despite challenges in the healthcare sector. The company focuses on automation and innovation to navigate budget constraints and workforce shortages, aligning with its vision of the Autonomous Pharmacy.
February 05, 2026 Omnicell Reports Financial Results for Fiscal Year and Q4 2025 Omnicell reported a slight revenue increase in Q4 2025 despite a net loss. The company anticipates continued growth in 2026, driven by innovative products and expanding recurring revenue.
January 13, 2026 Omnicell Inc. Set to Announce Fourth Quarter and Full Year 2025 Financial Results Omnicell, Inc. is set to announce its financial results for Q4 and the full year 2025 on February 5, 2026. The event includes a conference call to discuss financial outcomes and company strategies in healthcare technology.
December 08, 2025 Omnicell Inc. Launches Titan XT: A Leap Forward in Automated Medication Management Omnicell has launched the Titan XT, a cutting-edge automated dispensing system that integrates advanced automation and intelligence for improved medication management. Featuring tools like DynamicRestock and AI-driven insights, Titan XT aims to streamline workflows, reduce errors, and empower nursing teams. Available now in the U.S., this system is set to redefine operational efficiency in healthcare.
December 01, 2025 Omnicell Inc. Prepares to Showcase Innovations at ASHP Midyear Clinical Meeting Omnicell, Inc. is set to present its innovative solutions at the ASHP Midyear Clinical Meeting on December 8, 2025. Attendees will experience advancements in healthcare technology and participate in a Q&A session with key executives, reinforcing Omnicell's commitment to transforming care delivery.
November 20, 2025 Omnicell Inc. Set to Present at Piper Sandler 37th Annual Healthcare Conference Omnicell, Inc. will present at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025. The event highlights their innovative solutions designed to improve efficiency and outcomes in healthcare settings.
November 13, 2025 Omnicell Inc. Achieves URAC Certification, Bolstering Specialty Pharmacy Services Omnicell, Inc. has received URAC Health Care Management Certification, affirming its commitment to high-quality specialty pharmacy services. This certification empowers health systems to manage their own specialty pharmacy operations, enhancing compliance and operational performance.
November 05, 2025 Omnicell Inc. Reports Strong Q3 2025 Results Amidst Market Challenges In Q3 2025, Omnicell, Inc. reported revenues of $310.6 million, driven by product and service expansion, despite rising operating costs. The company emphasizes innovation and operational efficiency while navigating market challenges.
October 30, 2025 Omnicell Reports Strong Third Quarter 2025 Financial Results Omnicell Inc. announces strong Q3 2025 financial results, with revenues of $311 million, a 10% increase from last year. The company emphasizes growth driven by connected devices and strategic partnerships, reaffirming its positive outlook for the remainder of the year.
October 06, 2025 Omnicell Inc. to Announce Q3 2025 Financial Results Omnicell, Inc. is set to announce its Q3 2025 financial results on October 30, 2025, followed by a conference call. Investors will gain insights into the company's innovations and strategic direction in healthcare technology.
August 06, 2025 Omnicell Inc. Reports Strong Q2 2025 Results: A Step Forward in Autonomous Pharmacy Solutions Omnicell Inc. has reported strong Q2 2025 results with revenues reaching $290.5 million, a notable increase from last year. The company is focused on expanding its product offerings and enhancing market position amid economic challenges, reflecting its commitment to innovation in pharmacy care delivery.
May 14, 2025 Omnicell Unveils New Innovation Lab in Austin to Transform Healthcare Operations Omnicell has launched a new Innovation Lab in Austin to address healthcare challenges through advanced technologies and automation. The lab aims to enhance efficiency and alleviate staff burnout by developing rapid solutions for medication and supply management.
May 14, 2025 Omnicell Unveils Innovative Solutions to Enhance Medication Management in Healthcare Omnicell has unveiled innovative products, including the MedTrack RFID Line and MedVision software, to enhance medication management in healthcare settings. These solutions leverage RFID technology and intelligent workflows to reduce errors, improve inventory management, and increase operational efficiency.
May 07, 2025 Financial Review of Omnicell Inc.: Q1 2025 Highlights Omnicell Inc. reported a revenue increase to $269.6 million in Q1 2025, despite a net loss of $7.02 million. The company is focused on expanding its market presence and navigating challenges from global trade relations.
May 06, 2025 Omnicell Inc. Reports Strong Q1 2025 Results Amid Tariff Uncertainty Omnicell, Inc. announced a strong financial performance in Q1 2025, with revenues of $270 million, marking a 10% increase from last year. The company improved its non-GAAP earnings significantly while navigating tariff-related challenges. Key developments include the upcoming Austin Innovation Lab opening and a revised financial guidance for the year.
April 14, 2025 Omnicell Inc. Set to Announce Q1 2025 Financial Results Omnicell, Inc. is set to announce its Q1 2025 financial results on May 6, 2025, followed by a conference call at 8:30 a.m. ET. The company aims to provide valuable insights into its performance and strategic direction amidst an evolving healthcare landscape.
March 12, 2025 Omnicell Announces Chief Financial Officer Transition: A Strategic Move for Growth Omnicell, Inc. announces the departure of CFO Nchacha Etta effective September 15, 2025, as it seeks a successor. This leadership change aims to support the company’s strategic growth while maintaining its financial guidance for 2025.
February 27, 2025 Omnicell Inc. Reports 2024 Annual Results: A Year of Strategic Adjustments and Growth Challenges Omnicell Inc.'s 2024 annual report outlines a challenging year marked by revenue declines and strategic realignments. Despite setbacks, the company emphasizes innovation through its Autonomous Pharmacy initiative, aiming for future growth in the healthcare sector.
February 06, 2025 Omnicell Reports Fiscal Year and Fourth Quarter 2024 Results Omnicell, Inc. announced a 19% revenue increase in Q4 2024, signaling recovery from previous challenges. The company reported improved profitability metrics and strategic initiatives aimed at long-term growth as it looks forward to 2025.
January 23, 2025 SWOT Analysis of Omnicell Inc. in 2025 This SWOT analysis of Omnicell Inc. in 2025 reveals its market leadership, innovative technology, and comprehensive product range. However, challenges like high debt and intense competition pose significant risks. Opportunities in automation and healthcare expansion may drive future growth.
November 08, 2024 Omnicell Inc. Reports Mixed Results in Q3 2024 Financial Report Omnicell Inc. reports a revenue decline in Q3 2024, driven by lower product sales, but net income improves due to higher non-operating income. The company focuses on operational efficiency and strategic growth amidst changing healthcare dynamics.
August 06, 2024 Omnicell Inc. Reports Q2 2024 Financial Results: A Closer Look at Revenue and Profitability Omnicell Inc. reported a revenue decline to $204.8 million in Q2 2024, driven by lower product sales, while service revenues grew. The company emphasizes innovation in its Autonomous Pharmacy vision amidst cost management strategies.
May 07, 2024 Omnicell Inc. Reports Q1 2024 Results: Navigating Challenges and Opportunities Omnicell Inc. reported a revenue decline in Q1 2024, with total revenues of $234.1 million compared to $286.5 million in Q1 2023. Despite challenges, the company is focusing on strategic initiatives like the Autonomous Pharmacy to enhance efficiency and patient outcomes.